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Diet composition and insulin action in animals models
Abstract
Critical insights into the etiology of insulin resistance have been gained by the use of animal models
where insulin action has been modulated by strictly controlled dietary interventions not possible in human
studies. Overall, the literature has moved from a focus on macronutrient proportions to understanding the
unique effects of individual subtypes of fats, carbohydrates and proteins. Substantial evidence has now
accumulated for a major role of dietary fat subtypes in insulin action. Intake of saturated fats is strongly
linked to development of obesity and insulin resistance, while that of polyunsaturated fats (PUFAs) is not.
This is consistent with observations that saturated fats are poorly oxidized for energy and thus readily
stored, are poorly mobilized by lipolytic stimuli, impair membrane function, and increase the expression of
genes associated with adipocyte profileration (making their own home). PUFAs have contrasting effects
in each instance. It is therefore not surprising that increased PUFA intake in animal models is associated
with improved insulin action and reduced adiposity. Less information is available for carbohydrate
subtypes. Early work clearly demonstrated that diets high in simple sugars (in particular fructose) led to
insulin resistance. However, again attention has rightly shifted to the very interesting issue of subtypes of
complex carbohydrates. While no differences in insulin action have yet been shown, differences in
substrate flux suggest there could be long-term beneficial effects on the fat balance of diets enhanced in
slowly digested/resistant starches. A new area of major interest is in protein subtypes. Recent results
have shown that rats fed high-fat diets where the protein component was from casein or soy were insulinresistant, but when the protein source was from cod they were not. These are exciting times in our
growing understanding of dietary factors and insulin action. While it has been clear for some time that
'oils ain't oils', the same is now proving true for carbohydrates and proteins.
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Critical insights into the etiology of insulin resistance have been gained by the use of animal
models where insulin action has been modulated by strictly controlled dietary interventions not
possible in human studies. Overall, the literature has moved from a focus on macronutrient
proportions to understanding the unique effects of individual subtypes of fats, carbohydrates and
proteins. Substantial evidence has now accumulated for a major role of dietary fat subtypes in
insulin action. Intake of saturated fats is strongly linked to development of obesity and insulin
resistance, while that of polyunsaturated fats (PUFAs) is not. This is consistent with observations
that saturated fats are poorly oxidized for energy and thus readily stored, are poorly mobilized by
lipolytic stimuli, impair membrane function, and increase the expression of genes associated with
adipocyte profileration (making their own home). PUFAs have contrasting effects in each
instance. It is therefore not surprising that increased PUFA intake in animal models is associated
with improved insulin action and reduced adiposity. Less information is available for carbohydrate
subtypes. Early work clearly demonstrated that diets high in simple sugars (in particular fructose)
led to insulin resistance. However, again attention has rightly shifted to the very interesting issue
of subtypes of complex carbohydrates. While no differences in insulin action have yet been
shown, differences in substrate flux suggest there could be long-term beneficial effects on the fat
balance of diets enhanced in slowly digested/resistant starches. A new area of major interest is in
protein subtypes. Recent results have shown that rats fed high-fat diets where the protein
component was from casein or soy were insulin-resistant, but when the protein source was from
cod they were not. These are exciting times in our growing understanding of dietary factors and
insulin action. While it has been clear for some time that ‘oils ain’t oils’, the same is now proving
true for carbohydrates and proteins.
Dietary macronutrients: Energy balance: Insulin resistance

Background
Insulin resistance is a major player in the etiology of the
metabolic syndrome cluster of diseases. Dietary factors
undoubtedly influence insulin action, but it often appears
that agreement stops with these two statements. Ambrose
Bierce, in his wonderful tome The Devil’s Dictionary,
defined a Trinitarian as ‘one who denies the divinity of a
Unitarian’. Of course, a Unitarian was ‘one who denies the
divinity of a Trinitarian’. In many ways the argument
between the high carbohydrate versus fat-modified schools
of dietary advice have fallen into Bierce’s dichotomous trap.
Non-insulin-dependent or type 2 diabetes mellitus is the
most linear disease descendent of insulin resistance. The
prominent symptom, which provides the definition for the
disease, is the inability to handle carbohydrate. The logical
question is, why advocate a high-carbohydrate diet to
individuals whose core problem is that macronutrient?

The answer, at least partially, concerns the macronutrients
available to substitute for carbohydrate. There is limited
ability to realistically manipulate the levels of protein, and
therefore reducing carbohydrate comes at the cost of
increasing fat. Since obesity is also part of the metabolic
syndrome disease cluster, and insulin resistance is closely
linked with adiposity, then the argument that ‘eating fat
makes you fat’ comes into play. Fortunately, there is a way
forward. Experimental animal investigations of insulin
action, following manipulation not only of macronutrient
proportions, but more particularly of macronutrient subtypes, is writing an exciting new story on diet and insulin
action.
‘Oils ain’t oils’
The experimental animal literature on dietary fat subtypes is
now quite large and coherent. There is evidence for both
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direct effects on insulin action and indirect effects via
induction of obesity. The literature on both has recently
been reviewed, and only a summary is needed here with the
focus on mechanistic insights.
‘Eating fat makes you fat’ is catchy but not well supported as a global concept. Overall there is now an enticing
literature which links intake of saturated fats with development of obesity, but contrasts a neutral, or even protective,
effect of polyunsaturated fatty acids (PUFAs) (Pan et al.
1994; Storlien et al. 1998). Compared to saturated fats,
PUFAs are more readily used for energy when initially
ingested (Leyton et al. 1987). This was demonstrated by
observing labelled CO 2 production after oral administration
of identical amounts of differently labelled fatty acids.
Dramatic differences were observed over the subsequent
24 h, with only a small proportion of the saturated fats being
fully used for energy compared to unsaturated fats (Leyton
et al. 1987). The implication is that the saturated fats are
being stored in adipose tissue depots. Once stored there,
saturated fats are also less readily mobilized by lipolytic
stimuli (Mougios et al. 1995; Halliwell et al. 1996; Raclot
et al. 1997). Increasing the degree of unsaturation at a given
carbon chain length increases the relative mobilizability of
stored fats. This has an interesting implication for physically
active individuals, where selective mobilization of unsaturated fats (Mougios et al. 1995), combined with the greater
propensity of these fats for utilization as energy, means that
such individuals are in danger of ‘saturating down’ their
body lipid stores. As we shall see, this has potentially
negative consequences for a number of aspects of metabolism. Lipids are not just an efficiently stored energy reserve,
they form the membranes of all cells and organelles. Here
again, when saturated fats are incorporated into membranes
they have the capacity to reduce metabolic rate and decrease
receptor (e.g. beta adrenoceptor) binding (Matsuo & Suzuki,
1997) with the obvious implications for energy balance.
Conversely, addition of n-6 PUFAs to the diet can increase
beta adrenoceptor affinity (Nicolas et al. 1991).
In addition to their roles as energy and cell-structural
elements, it is now clear that fatty acids act as potent gene
regulators, notably in the current context on enzymes of
endogenous lipid synthesis and adipocyte proliferation
(Clarke et al. 1997). The beautiful pattern persists, with
saturated fats up-regulating, and PUFAs down-regulating,

these enzymes. Saturated fats are then not only adept at
finding their way into the body’s stores and resistant to
being winkled out, but proficient at making their own home
– good friends in times of want but pernicious in the face of
plenty. Finally, a more recent angle on fats and energy
balance has been exposed (see Table 1). In mice fed diets
high in saturated fats, neuronal activation was seen in the
dorsal-lateral hypothalamus, the classic ‘feeding centre’,
while activity in the ventromedial hypothalamic satiety
centre was suppressed (Wang et al. 1999). This is in line
with development of excess adiposity via a tilting of the
autonomic nervous system balance to favour parasympathetic over sympathetic. This pattern was in contrast to
PUFA feeding where only an increase in ventromedial
hypothalamic neuronal activity was observed, and even
less fat accumulated than in low fat-fed control mice
(Wang et al. 1999). It is important to link this new
information with previous work which has demonstrated an
increase in stress responsivity (indexed by blood glucose and
corticosterone response, and hypothalamic noradrenaline
turnover) with high-fat feeding (Pascoe et al. 1991).
The pattern of low sympathetic nervous system activity/
basal metabolic rate and increased stress responsivity is a
feature of many animal models of the metabolic syndrome.
It is perhaps not surprising that the antiglucorticoid RU486
(Kusunoki et al. 1995), and the alpha-2 adrenoceptor
agonist clonidine (Rocchini et al. 1999), have both been
shown to ameliorate the insulin resistance of high-fat
feeding.
To complete this compelling pattern of dietary fat subtype effects, there is now evidence that ‘dietary fatty acid
composition, independent of adipose tissue mass, is an
important determinant of circulating leptin level’, with
PUFA-enriched diets leading to much higher leptin levels
than those enriched in saturated fats (Cha & Jones, 1998).
This suggests the possibility that there may even be an effect
on the intake side of the energy-balance equation to help
explain the anti-obesogenic effects of PUFAs.
As well as the indirect route via obesity, there is strong
evidence that dietary fat subtypes are also able to modulate
insulin action more directly (Storlien et al. 1996). Early
in vitro studies provided evidence that changes in the
composition of fatty acids within membrane phospholipids
influenced insulin action, altering both insulin binding and

Table 1. Effects of 1 week of feeding diets high in carbohydrate, saturated fat or
polyunsaturated fats on neuronal (c-fos) activation (high-carbohydrate diet set at 100 %)
Lateral hypothalamus*

Ventromedial hypothalamus†

Energy balance

Feeding

Satiety

ANS association

Parasympathetic

Sympathetic

Neuronal activity (%)
high carbohydrate diet
high saturated fat diet
High PUFA diet

100
367
108

100
33
167

* The lateral hypothalamus has traditionally been viewed as a feeding centre and aligned with the
parasympathetic arm of the autonomic nervous system (ANS). Activation of the lateral hypothalamus
is thus associated with positive energy balance.
† The ventromedial hypothalamus is considered a sympathetic nervous system-linked satiety centre,
activation of which will induce negative energy balance.
Adapted from Wang et al. 1999.
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action. In general, the more saturated the fatty acids in
membrane phospholipid, the more deleterious the effect
(Grunfeld et al. 1981; Field et al. 1988). Further, there
was some evidence that the highly unsaturated n-3 fatty
acids were perhaps particularly beneficial (Sohal et al. 1992;
Clandinin et al. 1993). These studies were followed by
in vivo work combining the hyperinsulinaemic, euglycaemic
clamp technique with bolus injection of labelled glucose
and deoxyglucose to index insulin action in individual
tissues after various feeding regimens (Storlien et al.
1991). Skeletal muscle was targeted as the single most
important tissue of insulin-stimulated glucose uptake.
These studies showed that feeding rats for short (3–4week) periods on isocaloric diets, differing only in their
fatty acid profile, was sufficient to provoke major insulin
resistance in some, but not all, high fat-fed groups. Rats fed
diets high in n-3 PUFAs, and with a low n-6 : n-3 PUFA
ratio, maintained normal insulin action. Diets high in
saturated and monounsaturated fats led to profound insulin
resistance in numerous tissues, as did diets with a higher
level of PUFAs where those PUFAs were of the n-6 class
(Storlien et al. 1991).
A variable linked early with whether or not a diet group
developed skeletal muscle insulin resistance was the fatty
acid composition of membrane structural lipids in skeletal
muscle (Storlien et al. 1991). This work has been replicated
a number of times in rodent models and in a number of
human populations (Storlien et al. 1996). In addition,
pharmaceutical insulin sensitizers such as bezafibrate
(Matsui et al. 1997) and benfluorex (L. H. Storlien, unpublished results) also unsaturate lipids, which may be an
important part of their mode of action. However, the
mechanistic basis of altered membrane lipid composition
directly influencing insulin action is not entirely established.
There are a number of possibilities, including effects on
translocation and intrinsic activity of the insulin-regulatable
glucose transporter GLUT4 (Zierath et al. 1997; Hansen et
al. 1998). These workers have shown substantial impairment of insulin-stimulated muscle glucose transport, along
with reduced GLUT4 translocation to the membrane, following high-fat feeding in rats. However, no information is
yet available regarding these metabolic elements and dietary
fatty acid profiles which do not lead to insulin resistance.
Specific diacylgycerol–protein kinase C interactions may
be important. Activation of protein kinase C epsilon is
associated with skeletal muscle insulin resistance in high
fat-fed rats (Schmitz-Peiffer et al. 1997), and it is possible
that interaction with specific fatty acid subtypes in diacylglycerols modulates this activation. Also, there are possible
mechanisms via influences on nitric oxide production,
eicosanoid balance and ion flux. However, no specific
work has yet borne fruit in these directions.
One final aspect of fatty acid profile which must be
considered is the potential effects at the level of the
pancreas. It is now clear that insulin secretion is powerfully,
and differentially, influenced by individual fatty acids (Stein
et al. 1997), with saturated fats in particular leading to
hypersecretion of insulin. Hyperinsulinaemia per se may
lead to insulin resistance.
A second variable identified in early studies as important
for insulin action was muscle storage triglyceride (TG)
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levels, impaired insulin action being closely associated
with high muscle TG levels (Storlien et al. 1991). This
observation has now been replicated in human studies
(Phillips et al. 1996; Pan et al. 1997). Some concern had
been expressed about the location of the TG, but in vivo
NMR studies have been used to show that the relevant
TG was intracellular (Krssak et al. 1999). Using a more
direct approach, we have recently measured insulinstimulated glucose uptake in incubated soleus muscle
using the 2-deoxyglucose method, and then measured TG
in muscle fibres alone after stripping away all interstitial fat
and connective tissue. Again, a highly significant inverse
relationship was found between intramyocyte TG and insulinstimulated glucose metabolism (T. C. Thomas & L. H.
Storlien, unpublished results).
The possibility has been suggested that the concentration
of long-chain fatty acyl-CoA is a marker for skeletal muscle
TG hydrolysis, and accounts for the inhibitory effect of
muscle TG levels on insulin action (Oakes et al. 1997). The
observation that addition of cholate to a high-fat diet
improves insulin is interesting (Ikemoto et al. 1997), in
particular given the data showing that, at least in the liver,
changes in TG accumulation paralleled the cholate-induced
decline in acyl-CoA synthetase mRNA.
This brings into focus our lack of knowledge about what
actually controls the accumulation and distribution of TG in
skeletal muscle. It is clear that it is not just the total
intramyocyte TG that modulates insulin action, but its
distribution is also critical. Muscle TG is substantially
elevated in trained, compared to sedentary, individuals,
but insulin action is improved. Female rats, given access to
running wheels, will build up to an average of over 10 km/d.
We have exploited this chronic exercise model to investigate, using electron microscopy, the effect of ‘training’
on both amount and distribution of intramyocyte TG.
While the work is in its early stages, we can confirm that
intramyocyte TG is greatly elevated, with lipid droplets
very tightly coupled to mitochondria (P.L. Else et al.,
unpublished results). What controls this increase in
TG and its affinity for mitochondria and, in turn, why it
is not deleterious to insulin action are questions of importance in our understanding of skeletal muscle insulin
resistance.
Carbohydrate subtypes
Just as there are simple and complex carbohydrates, there
are simple and complex arguments about the level and form
of carbohydrate intake to optimize insulin action. From
experimental animal work simple sugars, compared to
complex carbohydrates, were found to have a negative
influence on insulin action. These studies were conducted
in rats and, as with the dietary fat subtype work described
above, consisted of a series of pleasingly simple interventions of 3–4 weeks with caloric intake matched and only
the carbohydrate type varied in the diet. Hyperinsulinaemic,
euglycaemic clamps were performed with tracer administration to assess insulin action at the level of the liver
and in individual skeletal muscles, and effects were found
in both. Diets where starch was largely substituted by
either sucrose or fructose were deleterious for insulin
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action (Storlien et al. 1988; Thorburn et al. 1989). The
hypertriglyceridaemic repercussion of elevated fructose
intake was seen as a likely intervening variable. Certainly,
changing the fat source to emphasize n-3 fatty acids ameliorates both the insulin resistance and hypertriglyceridaemia
of high sucrose feeding (Lombardo et al. 1996). Interestingly, glucose itself had no deleterious effect on insulin
action compared to starch. This suggests that the rate of
carbohydrate absorption does not, in the short term, alter
insulin action.
What is even less explored, and potentially of much
greater importance to the broader picture, are the effects
of various forms of complex carbohydrates. However, there
is considerable controversy even in relation to an acceptable
classification framework (Cummings et al. 1997) when we
start impinging on the grey area of resistant starches, soluble
fibre and large-bowel digestion (fatty acids again, of the
short-chain type).
The glycaemic index is a concept which has been around
for many years but still is shrouded in confusion and capable
of inciting some acrimony (Coulston & Reaven 1997;
Wolever 1997). There is still no evidence for direct beneficial effects of low glycaemic-index diets on insulin action
either in animal or human studies. However, there are a
number of very logical bases for suggesting that there may
well be a beneficial effect of slowly digested carbohydrates
in the long run.
Long-term feeding of diets high in carbohydrate, differing only in type of starch, has shown a differential influence
on the insulin response necessary to maintain essentially
normal glucose tolerance. Rats fed on a diet with amylopectin as the starch are markedly hyperinsulinaemic during
an intravenous glucose tolerance test compared to rats fed
a high-starch diet emphasizing amylose (Byrnes et al.
1995; Higgins et al. 1996). This relative hyperinsulinaemic
response becomes more pronounced the longer the feeding
period. Amylose is a straight-chain polysaccharide which,
by virtue of that configuration, is slowly digested. The
branched-chain configuration of amylopectin allows multiple access points for alpha-glucosidase attack and rapid
absorption.
At the molecular level, high-amylose starches have been
shown to increase GLUT4, and decrease fatty acid synthase
gene expression in rat epididymal tissue (Kabir et al. 1998b).
In addition, maximal insulin-stimulated 14C-glucose oxidation
was increased, whereas 14C-glucose incorporation into
lipids was decreased (Kabir et al. 1998a), and glycogen
synthesis in muscle was increased (Denyer et al. 1998), in
amylose-fed compared to amylopectin-fed rats. Taken
together, these results and those noted above are suggestive
of potential effects of amylose-enriched starches on insulin
secretion and/or on substrate repartitioning.
Finally, there are major developments in our understanding of the physiochemistry of starch and the increasingly
blurred boundaries between resistant starches and fibre.
There are few real data here in relation to insulin resistance,
an important emerging field of research.
Protein subtypes
Compared to fat and carbohydrate subtypes, proteins have

been under-studied. Some years ago we noted that rats fed a
synthetic diet were much more insulin-sensitive than
those fed on laboratory chow (Storlien & Jenkins, 1996).
This was puzzling as the synthetic diet had been prepared so
as to closely match the chow macronutrient distribution and
fatty acid profile. Since then, exciting new work has
demonstrated that changing the protein source in synthetic
diets can markedly dictate development, or not, of insulin
resistance in medium- to high-fat-fed rats (Iritani et al.
1997). Follow-up work has shown that high-fat diets prepared with cod protein, as compared to soy or casein protein,
do not lead to insulin resistance (Lavigne et al. 1999).
Further mechanistic investigations showed that the cod
protein improves GLUT4 translocation to skeletal muscle
T-tubules, but not to the plasma membrane (Tremblay et al.
1999). The T-tubule GLUT4 protein correlates with insulinstimulated glucose transport, and is most interesting in
terms of the possibility that a specific protein might be
critical in skeletal muscle insulin-stimulated glucose transport. The effect might be due to a specific protein which has
a gene-specific effect at the intestinal level, a protein which
escapes full digestion, a molecule which is co-extracted with
protein, or indeed a particular amino acid pattern unique to
cod. In this regard the observation that L-glutamine supplementation of a high-fat diet has beneficial effects on
glycaemia and insulinaemia in mice may be relevant
(Opara et al. 1996). The exploration of these possibilities
offers interesting new lines of research.
Summary
Animal models have proven useful in studies of the influence of dietary variables and insulin action. This manuscript
has focused on the macronutrients, and the overriding
message is that we must look beyond the broad categories
of fats, carbohydrates and proteins. A great deal of work has
been done on fatty acid subtypes, and a harmonious pattern
linking saturated fat intake, both indirectly and directly, to
insulin resistance is evident. In contrast, PUFAs are, if
anything, protective. Less is known about carbohydrate
subtypes. While clear data have been obtained regarding
the insulin resistance-inducing effects of sucrose, and in
particular its fructose moiety, little other direct evidence is
available on carbohydrate subtype–insulin action interactions. Finally, new work on protein sources and the profound differences in insulin action they induce is providing
interesting new avenues to explore. What is now clear, and
points in a particularly exciting direction, is that the macronutrients are all potent gene regulators – and subtype
mix will undoubtedly be found important in the precise
patterning of that gene regulation.
Research on experimental animals is important, for the
most part, only in its capacity to inform directions for
human work. This has happened in the field of diet and
insulin action, and there is potential for new and exciting
contributions. Our work has focused on macronutrient
subtypes, inter alia from the recognition that persuading
‘free range’ individuals to introduce and sustain changes
in the macronutrient proportions of their diet has proved
remarkably difficult, at least in our hands. However, changing
individual macronutrient subtype profiles is substantially
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easier with the resultant increased capacity for a significant
impact on the prevention and therapy of insulin resistance.
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